Acadia Healthcare (NASDAQ: ACHC) reported Q2 EPS of $0.92, $0.06 better than the analyst estimate of $0.86. Revenue for the quarter came in at $731.3 million versus the consensus estimate of $711.94 million.

GUIDANCE:

Acadia Healthcare sees FY2023 EPS of $3.25-$3.50, versus the consensus of $3.28. Acadia Healthcare sees FY2023 revenue of $2.86-2.9 million, versus the consensus of $2.857 million.

For earnings history and earnings-related data on Acadia Healthcare (ACHC) click here.